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Background   
Brain death triggers an inflammatory response that is associated with worse outcomes for 
recipients of transplanted organs procured from brain dead donors.  The intestine has 
been shown to release inflammatory mediators in other types of shock, but its role is 
brain death is not well described.  Direct peritoneal resuscitation (DPR) improves visceral 
organ blood flow and has been shown to reduce inflammation after hemorrhagic shock.  
Better understanding of this inflammatory process within the peripheral organs, the 
effects of DPR, and the role of the intestine could aid in better resuscitation of potential 
organ donors.   
Methods 
Male Sprague-Dawley rats were made brain dead by inserting a 4F Fogarty catheter into 
the skull and slowly inflating the balloon.  Rats were resuscitated with normal saline to 
maintain a mean arterial pressure of 80 mmHg and DPR animals also received an 
intraperitoneal injection of commercial peritoneal dialysis solution.  Rats were sacrificed 
at zero, two, four, and six hours after brain death.  Protein levels were assessed using 






neutrophil and macrophage infiltration.   
Results 
Flow cytometry demonstrates that macrophages and neutrophils infiltrate the liver, lungs, 
kidneys, and heart between four and six hours after brain death.  Brain death causes 
increases in serum levels of inflammatory mediators, as well as markers of intestinal 
injury, which are reduced by DPR.  A detailed examination of the lungs and kidneys 
showing that inflammatory cytokines, leukocyte adhesion molecules, and macrophages 
and neutrophils increase sequentially within the tissue after brain death, and that DPR 
reduces every one of these inflammatory stages. 
Conclusions 
These results suggest that multiple peripheral organs in rats experience an influx of 
leukocytes between four and six hours after brain death.  It appears that increased 
intestinal permeability contributes to this.  Using DPR affects every step of this process 
by maintaining intestinal blood flow, reducing the release of these pro-inflammatory 
signals, reducing adhesion molecule expression, and ultimately decreasing the 
macrophages and neutrophils that move into the tissues.  Use of DPR during resuscitation 
of brain dead patients has the potential to reduce systemic inflammation and provide 











TABLE OF CONTENTS 




LIST OF TABLES………………………………………………………………………..ix 
LIST OF FIGURES……………………………………………………………………….x 
 
CHAPTER 1: INTRODUCTION…………………………………………………………1 
Traumatic Brain Injury……………………………………………………………1 
 Physiology of Brain Death and Resuscitation…………………………………….1 
 Brain Death and Organ Donation…………………………………………………3 
 Inflammation in Brain Death……………………………………………………...3 
 Microcirculation and the Origins of DPR…………………………………………5 
 Cellular Mechanism of DPR………………………………………………………6 
 Direct Peritoneal Resuscitation in Shock………………………………………….7 
 Direct Peritoneal Resuscitation in Acute Brain Death…………………………….8 
 Cytokines and Leukocytes………………………………………………………...9 
 Leukocytes and Organ Transplantation…………………………………………...9 
 Summary…………………………………………………………………………10 
CHAPTER 2: MATERIALS AND METHODS………………………………………...11 
CHAPTER 3: HYPOTHESES AND SPECIFIC AIMS…………………………………16 
CHAPTER 4: TIMELINE OF NEUTROPHIL AND MACROPHAGE INFILTRATION 












CHAPTER 5: THE EFFECT OF DIRECT PERITONEAL RESUSCITATION ON 








CHAPTER 6: THE EFFECT OF DIRECT PERITONEAL RESUSCITATION ON 







CHAPTER 7: CONCLUSIONS…………………………………………………………91 
REFERENCES…………………………………………………………………………..95 







LIST OF TABLES 
TABLE          PAGE 
1. Lab Value Measurements……………………………………………………………..26 
2. Serum Cytokine Measurements……………………………………………………….36 
3. Lung Cytokine Measurements………………………………………………………...51 
4. Lung Pathology Descriptions………………………………………………………….64 






LIST OF FIGURES 
FIGURE          PAGE 
1.  Heart Rate over Time…………………………………………………………………23 
2.  Mean Arterial Pressure over Time……………………………………………………24 
3.  Blood Granulocytes over Time……………………………………………………….27 
4.  Blood Monocytes over Time…………………………………………………………28 
5.  Blood Monocyte Activation over Time………………………………………………29 
6.  Tissue Neutrophils over Time………………………………………………………...31 
7.  Tissue Macrophages over Time………………………………………………………32 
8.  Tissue Macrophage M1 Activation…………………………………………………...33 
9.  Tissue Macrophage M2 Activation…………………………………………………...34 
10.  Serum HMGB-1 and HSP70 Levels………………………………………………...35 
11.  Serum FABP and LPS Levels……………………………………………………….38 
12.  Ileum Immunohistochemistry Staining for ZO-1…………………………………...39 
13.  ICAM Levels in Lung……………………………………………………………….53 
14.  VCAM Levels in Lung……………………………………………………………...54 
15.  E-selectin Levels in Lung…………………………………………………………...55 
16.  P-selectin Levels in Lung……………………………………………………………56 
17.  Neutrophil Count in Lung…………………………………………………………...57 
18.  MPO Activity in Lung………………………………………………………………58 






20.  Macrophage Activation in Lung…………………………………………………….60 
21.  Lung Immunohistochemistry Staining for Macrophages…………………………...62 
22.  Lung Immunohistochemistry Staining for Neutrophils……………………………..63 
23.  ICAM Levels in Kidney……………………………………………………………..74 
24.  VCAM Levels in Kidney……………………………………………………………75 
25.  E-selectin Levels in Kidney…………………………………………………………76 
26.  P-selectin Levels in Kidney…………………………………………………………77 
27.  Neutrophil Count in Kidney…………………………………………………………79 
28.  MPO Activity in Kidney…………………………………………………………….80 
29.  Macrophage Count in Kidney……………………………………………………….81 
30.  Macrophage Activation in Kidney…………………………………………………..82 
















BACKGROUND AND REVIEW OF THE LITERATURE 
Traumatic Brain Injury  
 An average of 1.7 million people sustain a traumatic brain injury (TBI) in the 
United States every year.  Of these, 275,000 are hospitalized and 52,000 die [1].  It has 
been estimated that a moderate TBI can incur over $2.5 million, and treatment of a severe 
injury can cost over $5 million [2].  Thus, TBIs remain a significant cause of morbidity, 
mortality, and economic burden in the United States. 
 The severity of TBI extends across a spectrum.  A concussion is a mild form of 
TBI which is defined as a rapid, short-lived impairment of normal neurological function 
which normally resolves in 7-10 days [3].  A persistent vegetative state, commonly 
referred to as a coma, is a severe injury causing a lack of higher brain function.  These 
patients are unaware of their surroundings and have no motor or cognitive function, but 
respiration and circulation remain intact.  In contrast, brain death is equivalent to death, 
and includes a loss of spontaneous respiration and all other brain stem functions, in 
addition to the complete lack of cortical brain function [4]. 
Physiology of Brain Death and Resuscitation 
 Brain death occurs when a person suffers a TBI or stroke that leads to bleeding 
around or inside the brain which causes an increase in intracranial pressure (ICP).  In 
addition, the hypoxia and hypotension that frequently accompany traumatic injury lead to 






triphosphate (ATP) levels and subsequent dysfunction of ATP-dependent ion pumps.  
This causes electrolyte imbalances that lead to cellular edema, apoptosis, and release of 
inflammatory mediators, worsening this cellular swelling [5].  As the brain tissue expands 
in the enclosed space of the skull this increases ICP, pushing the brain downward through 
the foramen magnum, compressing the brain stem and causing ischemia and infarction. 
 As the brain stem dies, the patient undergoes significant physiological changes.  
First there is an intense increase in sympathetic outflow.  This leads to a rise in 
catecholamine levels, causing peripheral vasoconstriction and increased heart rate and 
blood pressure, leading to increased myocardial oxygen demand and pulmonary 
hypertension.  This increased oxygen demand combined with coronary vasoconstriction 
can cause cardiac ischemia, arrhythmias, and cardiac dysfunction.  Following this 
“sympathetic surge” there is a complete loss of sympathetic outflow, leading to profound 
peripheral vasodilation and hypotension.  In addition there are significant endocrine 
changes leading to low levels of thyroid hormone, antidiuretic hormone, and insulin, 
leading to significant electrolyte abnormalities, worsening hypotension, and 
hyperglycemia [6].  Therefore, prompt and aggressive support of these patients is 
necessary to prevent cessation of cardiac function. 
 The focus of resuscitation in brain death is maintaining blood pressure in order to 
maintain organ perfusion.  This frequently involves the infusion of large volumes of 
intravenous (IV) fluids.  This helps replace the water loss after the development of 
diabetes insipidus and also helps maintain blood pressure and organ perfusion.  
Ionotropes such as epinephrine or norepinephrine may also be used to support blood 






insulin, thyroid hormone, steroids, and vasopressin further support blood pressure and 
prevent electrolyte irregularities.  Mechanical ventilation is also necessary as respiratory 
function ceases after brain death [6-8].  Supporting blood pressure and ventilation in 
these ways helps maintain organ perfusion and tissue oxygenation, preserving organ 
function. 
Brain Death and Organ Donation 
 Resuscitation of brain dead patients is important because brain dead subjects have 
the potential to become organ donors.  Organ transplantation is frequently the best or 
only option for end-stage organ failure.  As the world’s population has increased and 
aged, the number of patient’s awaiting organ transplanted has rapidly outgrown the 
number of available organs.  Between 2009 and 2013 there were an average of 28,533 
solid organ transplants in the United States [9], and worldwide in 2011 there were over 
112,000.  However, this represents only about 10% of the current demand [10], and as 
many as 17 people per day die while on the waiting list [8].  Thus, different strategies are 
being developed to encourage organ donation, increase the number of organs transplanted 
from an individual donor, and also to improve the longevity of organs after 
transplantation in order to prevent the need for a single patient to be placed back on the 
list for repeat transplantation. 
Inflammation in Brain Death 
 The purpose of resuscitation is also to prevent inflammation and multiple organ 
system failure, even in patients with isolated brain injuries.  A mild or moderate response 
is normal and likely beneficial as part of the body’s stress response to trauma, but an 






failure develops, mortality can be anywhere between 30 and 100%, depending on the 
number of organs involved [13].  Research has demonstrated that any type of trauma can 
trigger a profound inflammatory response, which is largely is mediated by the intestine.  
This became evident after increasing numbers of patients underwent surgical exploration 
(or autopsy) for presumed intra-abdominal sepsis, only to find no identifiable source of 
infection.  This led to the hypothesis that bacteria from the intestine were moving into the 
blood stream and exacerbating organ dysfunction, a process known as “bacterial 
translocation” [14].  This can occur because hypotension and shock lead to increased 
vascular permeability and edema in the visceral organs, causing sloughing of the 
intestinal mucosa and diminishing both the absorptive and barrier functions of the gut 
[13].  Not only does ischemia lead to dysfunction of endothelial cell tight junctions, 
which normally prevent the movement of bacteria and large molecules across the 
endothelial barrier, but also promotes the activation of gut-associated lymphoid tissue and 
augments the body’s inflammatory response [14].  The movement of bacteria, bacterial 
byproducts, or its associated endotoxin into the blood, as well as the exaggerated 
inflammatory response, can cause worsening hypotension and shock, resulting in a 
downward spiral that results in organ failure and death.  Improving intestinal blood flow 
in shock may reduce inflammation and improve outcomes. 
 Brain death is associated with significant inflammation, though the role of the 
intestine as a source of this inflammation has not been well-studied.  In an animal model 
of isolated brain death without other traumatic injury, there is a significant upregulation 
of systemic inflammatory mediators, as well as increased inflammatory cytokines within 






from the brain itself [16, 17] or from endothelial activation [18].  If the intestine were to 
play a role, targeting intestinal perfusion could reduce the inflammation associated with 
brain death. 
Microcirculation and the Origins of DPR   
 Peritoneal dialysis fluid is vasodilatory [19].  Intravital microscopy studies have 
demonstrated that application of commercial peritoneal dialysis fluid to the terminal 
ileum causes rapid and sustained vasodilation of five different levels of arterioles.  
Further study revealed that this dilation was due to the presence of hypertonic solution 
and did not occur with isotonic solution.  In addition, arteriolar vasodilation was 
independent of the pH of the solution [20].  
This observation led to the hypothesis that use of hyperosmotic solution in the 
abdomen during shock would help improve blood flow to the visceral organs, help 
maintain intestinal barrier function, and reduce the body’s inflammatory response.  This 
procedure is known as direct peritoneal resuscitation (DPR).  Use of colorimetric 
microspheres showed that use of DPR improved blood flow not only to the ileum, but 
also to the jejunum, pancreas, spleen, psoas muscle, diaphragm, and lung [21].  
Subsequent experimentation using in vivo microscopy in rats demonstrated that use of 
DPR improves blood flow to the terminal ileum and reduces organ edema compared to 
conventional IV resuscitation, even though normal hemodynamic measurements were 
achieved in both groups [22-24].   
More recent human studies have demonstrated that use of adjunctive DPR after 
hemorrhagic shock improves the time to abdominal closure, rate of primary fascial 






from septic shock reduced time on the ventilator and in the intensive care unit (ICU), 
reduced abdominal complications, and improved mortality [26].  Use of DPR in brain 
dead organ donors improved organ edema and hepatic blood flow, leading to improved 
organ procurement rate [27]. 
Cellular Mechanism of DPR 
 The observed changes in blood flow from using DPR are associated with 
alterations on the cellular level.  Normally hemorrhage leads to prolonged low blood flow 
leads to reduced oxygen delivery to the tissues.  This leads to lower production of ATP, 
which in turn causes dysfunction of the ion exchange pumps that require ATP to 
function.  This then leads to disruption of the electrochemical gradient across the cell 
membrane, causing water to enter the cell, leading to cellular swelling and cell damage 
[23].  The vascular endothelium is particularly vulnerable to an ischemia/reperfusion 
injury, especially the intestinal vasculature [28].  This dysfunction not only affects the 
permeability of this barrier, but also leads to a release of inflammatory mediators, 
increased expression of adhesion molecules, changes in vascular tone [29].  This loss of 
barrier function results in increased movement of fluid and proteins out of the 
intravascular space into the interstitial space, and increased expression of adhesion 
molecules leads to increased movement of leukocytes into the tissues [30].  This causes 
organ edema and dysfunction, and can result in multi-system organ failure and death. 
 The function of DPR is to prevent this process.  By dilating the vasculature in 
shock, blood flow is maintained, particularly to the visceral organs.  Thus, oxygen 
delivery and ATP production are maintained.  This maintains the cellular electrochemical 






mediators and expression of adhesion molecules.  Thus peritoneal resuscitation not only 
works macroscopically by maintaining visceral organ blood flow, but also works on the 
cellular level to prevent the release of mediators which would otherwise cause organ 
dysfunction. 
Direct Peritoneal Resuscitation in Shock 
 Extensive study using a rat model revealed numerous benefits of the use of DPR 
during resuscitation after hemorrhagic shock.  Both animals that received conventional 
IV fluid resuscitation (CR) alone and those that received DPR showed the expected drop 
in blood pressure during hemorrhage, and return to baseline with resuscitation [21, 22, 
24].  However, CR animals experienced progressive intestinal vasoconstriction, whereas 
DPR was associated with dilation of the visceral vasculature and increased splanchnic 
blood flow [24].  Use of DPR also resulted in less edema formation in the liver, spleen, 
and lung [22].   
 The fact that an application of DPR to the abdominal cavity caused changes in 
lung edema suggests that DPR does not work merely through direct contact, but is having 
truly systemic effects.  This improvement in visceral blood flow leads to a reduction in a 
number of inflammatory mediators released in response to shock.  In an experiment 
comparing animals that received a sham procedure (no hemorrhage) to those which 
received CR or DPR, serum levels of inflammatory cytokines IL-1α, IL-1β, IL-6, IL-17, 
and IL-18 were equivalent to sham levels in the DPR animals and both were significantly 
lower than those in the CR group [31, 32]. 
 Peritoneal resuscitation also exerted effects on damage-associated molecular 






external pathogens, activating toll-like receptors that initiate the body’s inflammatory 
response [33, 34].  For example, High-Mobility Group Box 1 protein (HMGB-1) is a 
DAMP which helps facilitate transcription and is normally sequestered in the nucleus due 
to its powerful inflammatory properties [35-38].  Serum levels of HMGB-1 were 
increased in the CR group and equivalent to sham levels in the DPR group.  
Immunohistochemistry (IHC) staining further demonstrated that HMGB-1 remained in 
the nucleus in the DPR animals while migrating to the cytosol in the CR animals [smith 
thesis].  Both of these findings indicate that DPR helps reduce inflammation and preserve 
cell structure.  Hyaluronic acid (HA) is another DAMP which is found throughout the 
body, particularly in connective tissue [39].  Hyaluronan also forms a part of the 
connections between cells, and elevated levels in blood have been linked to sepsis, 
cirrhosis, and other serious conditions [39, 40].  Serum levels of HA were also increased 
in the CR group and reduced in the DPR group [smith thesis].  This implies that use of 
DPR not only decreases the production of these inflammatory mediators, but also helps 
maintain tight junction integrity, reducing the permeability of the endothelial cells and 
preventing leakage of DAMPs into the blood. 
Direct Peritoneal Resuscitation in Acute Brain Death 
 Direct peritoneal resuscitation has also been applied to a rat model of acute brain 
death.  In these experiments, rats that received targeted IV fluid (TIVF) resuscitation to 
maintain a mean arterial pressure (MAP) of 80 mmHg were compared to those that 
received TIVF and DPR.  Liver blood flow in the DPR group was higher than that in the 
TIVF group.  In addition, this result was achieved with significantly less IVF.  This 






was observed in hemorrhagic shock, DPR after acute brain death was also associated with 
a reduction in inflammatory cytokines including IL-1α, IL-1β, IL-4, IL-6, IL-13, IL-18, 
and IFN-γ [41]. 
Cytokines and Leukocytes 
 These changes in cytokine levels may correlate with changes in leukocyte 
activity, as numerous cytokines act on leukocytes, specifically macrophages and 
neutrophils, to recruit and activate them.  Neutrophils have been shown to secrete TNF-α, 
IL-1β, TGF-β, IFN-γ as well as IL-6, IL-8, IL-10, IL-12 [42, 43].  Monocytes (immature 
macrophages) have also been shown to produce TNF-α, TGF-β, and IL-8 [43].  Activated 
macrophages produce numerous cytokines including IL-1, IL-6, IL-12, and TNF-α [44].  
The endothelium also produces a number of cytokines which are used to attract immune 
cells after injury, such as IL-1α, IL-6, IL-8, TNF-α [45].  Macrophages and neutrophils 
activate and modulate each other’s activity, as well as that of other immune cells, such as 
T cells [46, 47].  Therefore, the changes in cytokine levels seen with the addition of DPR 
suggests that there may be a modulation of the underlying immune response. 
Leukocytes and Transplantation 
 The activity of leukocytes is extremely important in acute brain death because the 
success of organ transplantation is linked to leukocyte activity.  When an organ is 
transplanted, resident macrophages from the donor are transplanted within the organ 
tissue.  These remain in place and reproduce for approximately 4 weeks, after which they 
start to decline.  The recipient’s macrophages also move into the organ within 24 hours of 
transplantation and begin to proliferate [48].  However, while the presence of resident 






organ is associated with organ acute and chronic organ rejection [48-50], which results in 
reduced graft survival.   
Neutrophils also play an important role in the immune response after 
transplantation.  Neutrophils accumulate in the lungs only a few hours after an ischemia-
reperfusion injury [50], and studies of cardiac allografts demonstrate prolonged survival 
in recipients lacking the neutrophil chemokine receptor CXCR2 [51].  Neutrophils also 
work in conjunction with macrophages, complementing and activating each other, to 
protect the body from pathogens [46, 47].  Striking a balance between leukocyte 
activation and suppression after transplantation is difficult, delicate work as leukocytes 
are necessary for wound healing and prevention of infection, but over-activation of 
macrophages and neutrophils can lead to organ rejection. 
Summary 
 Previous evidence links DPR to the actions of leukocytes in shock.  Use of DPR 
causes vasodilation of the microvasculature in the visceral organs after shock.  This 
improves blood flow, reducing the permeability of the intestine during shock and quells  
the release of inflammatory mediators.  This may, in turn, cause reduced movement of 
leukocytes into organs as well as reduced activation of those cells.  This reduction in 
leukocytes could ultimately result in organs which have lower rejection rates and better 
outcomes after transplantation.  This goal of this project was the better delineate the 
course of inflammation and leukocyte infiltration into organs that occurs after acute brain 









MATERIALS AND METHODS 
 Animals were maintained at the Veterans Affair Hospital Research Facility in 
Louisville, KY which is approved by the American Association for the Accreditation of 
Laboratory Animal Care.  This protocol was approved by the Institutional Animal Care 
and Use Committee.  All experiments were performed using male Sprague-Dawley rats 
weighing 250-300g.  The individual rats used in each group were chosen using a random 
number generator iPhone application.  They were given food and water ad lib and were 
acclimated using 12 hour light/dark cycles for at least 7 days prior to use.   
 Anesthesia was initiated with intraperitoneal (IP) pentobarbital (50mg/kg) and 
maintained with subsequent IP injections of 10-25% of the original dose.  Body 
temperature was maintained at 37.0±1.0°C with a rectal probe and a servo-controlled 
heating pad.  Once loss of withdrawal reflexes was confirmed, an incision was made 
along the anterior surface of the neck.  The trachea was isolated, a tracheotomy made and 
a tracheostomy inserted (Intramedic PE-240 polyethylene tubing, Clay Adams Division 
of Becton Dickinson & Company, Parsipanny, NJ).  Animals were allowed to 
spontaneously breathe room air.  Then the right carotid artery was isolated and 
cannulated with PE-50 tubing.  This was then connected to the monitor to record 
continuous heart rate (HR) and mean arterial pressure (MAP).  The right internal jugular 
vein was cannulated and used to administer intravenous fluids.  The rat was then placed 






connective tissue and cleaned with acetone.  A drill was then used to create a small 
opening in the outer layer of the skull.  Forceps were used to remove the inner layer of 
the skull and enter the epidural space.  A 4F Fogerty catheter was inserted slowly into 
this space with the balloon completely deflated.  The rat was then returned to the supine 
position and allowed to equilibrate for 20 minutes.   
 Baseline MAP and HR measurements were taken 10 minutes apart after the 
equilibration period was complete.  After the second measurement was taken the epidural 
catheter was inflated at a rate of 1cc/hr.  During the inflation period MAP and HR were 
recorded every 5 minutes.  When the sympathetic surge was seen, the tracheostomy was 
connected to the ventilator and the rat was ventilated at a tidal volume of 1.5cc and a rate 
of 90 breaths/minute.  If at any point during the balloon inflation the rat began displaying 
signs of respiratory distress, the ventilator was connected at that time.  Once the MAP 
began to drop, IV normal saline (NS) was infused as necessary to maintain a MAP of 80 
mmHg.  Animals scheduled for DPR received a single IP injection of 30cc of 2.5% 
glucose-based clinical peritoneal dialysis solution (Delflex®, Fresenius USA, Inc. Ogden, 
UT) that contains 5.67 g/L sodium chloride, 3.92 g/L sodium lactate, 0.257 g/L calcium 
chloride, 0.152 g/L magnesium chloride at a pH of 5.5 and osmolality of 398 mOsm/L). 
Peritoneal resuscitation solutions were pre-warmed to 37°C prior to injection.   
 Animals were sacrificed at the time of resuscitation (time zero), two, four, or six 
hours post-resuscitation.  Sham animals underwent cannula placement and the drilling of 
the hole in the skull but did not undergo the brain catheter placement or inflation.  They 
were sacrificed at 2 hours.  At the time of sacrifice the lung, liver, heart, spleen, kidney, 






Normal Buffered Formalin (NBF) for histology.  Samples of liver, kidney, heart, and 
lung were also preserved for flow cytometry.  For this, 250 mg of lung tissue and 500 mg 
of kidney, heart, or liver tissue was cut into small pieces, then allowed to digest with a 
0.1% collagenase solution for 30 minutes at 37°C.  The solution was then strained 
through a 70 μm cell strainer to remove excess tissue.  The solution was centrifuged and 
the cells resuspended in DPBS solution to remove excess enzyme solution.    This was 
centrifuged again and resuspended in a 1% paraformaldehyde (PFA) solution and 
allowed to fix for 20 minutes at room temperature.  The cells were then washed with 
DPBS and resuspended and stored in 1mL of a solution of 70% DPBS, 20% calf serum, 
and 10% glycerol and frozen at -80°C.   
 To prepare samples for flow cytometry, they were thawed and 500 μL of the 
tissue digestion was stained using the Foxp3 Staining Buffer Set (eBioscience).  
Antibodies used included Anti-CD163:FITC (Bio-Rad);  Anti-CD68:Alexa Fluor 700 
(Bio-Rad); Anti-CD80:APC (Life Technologies); Anti-CD11b/c:PE-Cy 7 (BD 
Bioscience); and Anti-RP-1:PE (BD Bioscience).  Neutrophils were identified by the 
presence of CD11b and RP-1 [52, 53] and macrophages by CD68 [54].  Macrophage 
activation was represented CD80 for M1 activation and CD163 for M2 activation [54, 
55].  Flow cytometry was formed using a Becton Dickinson LSR II detector with lasers at 
405 nm, 488 nm, and 633 nm.   
 Whole blood was drawn at the time of sacrifice and a complete metabolic panel 
(CMP) was measured using the Abaxis VetScan VS2.  For store prior to flow cytometry, 
whole blood was centrifuged and the supernatant serum was separated and frozen.  The 






temperature, washed with DPBS, and stored in the DPBS/calf serum/glycerol solution.  
To prepare blood for flow cytometry 100 µL of blood were prepared using the same 
FoxP3 Staining Buffer Set and same antibodies as used in the tissue samples.  Flow 
cytometry was formed using the same detectors with lasers at 405 nm, 488 nm, and 633 
nm.   
 Analysis of protein levels was measured using quantitative ELISAs from LS Bio.  
In brief, tissues samples were lysed in buffer in the Tissue Lyser II.  A dilution series was 
created using the available standard and buffer.  Samples were then mixed in a 96-well 
plate with the provided buffer followed by substrate, washes, and stop solution according 
to the manufacturer’s instructions.  After the advised incubation period, plates were read 
at the recommended wavelength with a spectrophotometer.  The dilution series was used 
to create a standard curve and the results were analyzed using SigmaPlot (Systat Software 
Inc).   
 To perform immunohistochemistry staining, samples were imbedded in paraffin, 
sectioned, and placed on slides.  These were then stained with primary antibodies anti-
MPO for neutrophils, anti-CD68 for macrophages, and anti-ZO-1 (Abcam) using the 
Biocare system (Biocare Medical, LLC).  Light microscopy was then used to evaluate the 
position of macrophages and neutrophils within the tissue.  Tissue edema and damage 
was graded as mild, moderate, or severe by a blinded pathologist.  The pathologist graded 
tissue edema and hemorrhage on a scale of mild, moderate, or severe and graded the 
quantity of macrophages and neutrophils as few or numerous.   
 Statistical analysis was performed on the heart rate, blood pressure, and lab 






and flow cytometry.  Comparisons of heart rate, blood pressure, and lab values among all 
groups at the same time point were made using SPSS software (IMB) and an analysis of 
variance.  Comparisons between all groups in the MPO assay and quantitative ELISA 
carried out on SigmaPlot software (Systat Software, Inc) using an analysis of variance.  
Comparisons of quantitative values on flow cytometry over time were made using an 
analysis of variance using SPSS, while direct comparisons between a time point with and 




















HYPOTHESES AND SPECIFIC AIMS 
Overall Hypothesis 
The use of Direct Peritoneal Resuscitation reduces the early migration of macrophages 
and neutrophils into abdominal and thoracic organs when compared to conventional 
resuscitation alone in animals subjected to acute brain death. 
Specific Hypotheses and Specific Aims 
Hypothesis #1: Inflammation occurs rapidly after brain death, that increased intestinal 
permeability contributes to this inflammation, and that DPR will reduce systemic 
inflammation after brain death. 
Specific Aim #1: To create a timeline for inflammation and neutrophil and macrophage 
infiltration into the lung, liver, kidney, and blood, to study the permeability of the 
intestine over time, and how DPR affects intestinal permeability and subsequent 
inflammation in brain death. 
Hypothesis #2: Use of Direct Peritoneal Resuscitation reduces the infiltration of 
macrophages and neutrophils into the lung after brain death. 
Specific Aim #2: To evaluate the effect of DPR on the infiltration and activation of 
macrophages and neutrophils into the lung following acute brain death.  Animals will be 






(TIVF); 3) DPR (TIVF and 30cc intraperitoneal Delflex solution).   
Hypothesis #3: Use of Direct Peritoneal Resuscitation reduces the infiltration of 
macrophages and neutrophils into the kidney following brain death. 
Specific Aim #3: To evaluate the effect of DPR on the infiltration and activation of 
macrophages and neutrophils into the kidney following acute brain death.  Animals will 
be divided into 3 groups: 1) Sham (no brain death); 2) targeted IV fluid resuscitation 



















TIMELINE OF NEUTROPHIL AND MACROPHAGE INFILTRATION INTO 
ORGANS AFTER ACUTE BRAIN DEATH 
Overview 
Introduction 
Brain death triggers a significant inflammatory response that is associated with worse 
outcomes for recipients of transplanted organs procured from brain dead donors.  This 
inflammation has been hypothesized to arise from multiple sources, including the brain 
itself, or labile blood pressure causing ischemia/reperfusion injury and endothelial cell 
activation.  The intestine has been shown to release inflammatory mediators in other 
types of shock, but its role is brain death has not been well-studied.  Direct peritoneal 
resuscitation (DPR) improves visceral organ blood flow and has been shown to reduce 
inflammation after hemorrhagic shock.  Better understanding of this inflammatory 
process and the role of the intestine could aid in better resuscitation of potential organ 
donors.  We hypothesized that use of DPR would maintain intestinal integrity and reduce 
circulating inflammatory mediators after brain death. 
Methods 
Male Sprague-Dawley rats were anesthetized and had cannulas placed in the trachea, 
carotid artery, and internal jugular vein.  Brain death was induced by inserting a 4F 






achieved, rats were ventilated and resuscitated with normal saline to maintain a mean 
arterial pressure of 80 mmHg.  The DPR animals received a single injection of 30 mL 
intraperitoneal Delflex solution.  Animals were sacrificed immediately (time aero), or at 
two, four, or six hours after brain death.  Tissues were collected and snap frozen in liquid 
nitrogen or digested in collagenase to create a single cell suspension.  Lab values were 
measured from whole blood using the VetScan VS2.  Flow cytometry was performed 
using antibodies to CD11b and RP-1 for neutrophils and CD68 for macrophages.  Protein 
levels were measured using quantitative ELISA and cytokines were measured using the 
MagPix Luminex cytokine array. 
Results 
There were no differences in vital signs between the different groups.  Compared to the 
time zero rats, rats at two, four, and six hours had increased sodium and decreased 
glucose, albumin, total protein, alkaline phosphatase, and amylase.  Granulocytes or 
neutrophils were increased in the blood and all tissues as 6 hours compared to time zero, 
though only the blood, kidney, and lung reached statistical significance.  Monocytes or 
macrophages were unchanged in blood and increased in all tissues at six hours, though 
only the kidney and heart reached statistical significance.  Inflammatory cytokines IL-1β 
and IL-6 were increased at four hours, while damage associated molecular patterns 
HMGB-1 and HSP70 increased at two and six hours, respectively.  Levels of multiple 
inflammatory cytokines including IL-1β and IL-6 as well as HMGB-1 and HSP70 were 
decreased with DPR.  Fatty acid binding protein (FABP) and lipopolysaccharide (LPS), 
both markers of intestinal injury, were increased in the serum after brain death and 






part of tight junctions, showed decreased tight junction integrity after brain death, as was 
improved with DPR. 
Conclusions 
Our results demonstrate that brain death induces a rapid increase in a number of 
inflammatory mediators.  This is likely in part due to an increase in intestinal 
permeability.  These increased inflammatory mediators ultimately stimulate macrophages 
and neutrophils infiltrating the tissues at six hours.  Using DPR prevent intestinal 
ischemia and downregulates the systemic inflammatory response.  Procuring organs prior 
to six hours in rats, as well as therapies targeting at maintaining intestinal barrier function 



















 Brain death is associated with substantial physiologic changes, including 
myocardial and pulmonary dysfunction, as well as significant endocrine changes [6].  
Brain death also leads to an increase in systemic inflammation, as well as elevated 
inflammatory mediators within the end organs [56-58].  This inflammation has been 
hypothesized to lead to worse outcomes when patients receive transplanted organs 
procured from brain dead donors compared to living donors or those deceased after 
cardiac death [59, 60].  The cause of this inflammation is thought to arise from different 
sources.  Some studies suggest that inflammation may arise from the brain tissue itself 
and leak into circulation due to damage to the blood-brain barrier [16, 17].  The process 
of brain death is also associated with significant hemodynamic instability, including a 
rapid increase in circulating catecholamines and hypertension followed by profound 
peripheral vasodilation and hypotension [6].  This can lead to endothelial cell damage and 
upregulate inflammatory mediators [18].  However, while intestinal ischemia has been 
shown to be a significant source of inflammatory mediators in septic and hemorrhagic 
shock [14, 61, 62], its role as a source in brain death has not been well described.   
Numerous authors have examined levels of specific cytokines or leukocyte 
activity after brain death.  However, these studies are generally limited to a specific 
organ, and to a single or only a few time points after brain death.  They do not provide a 
true overall picture of how the process affects the body.  A better understanding of the 
process of brain death could allow for improved resuscitation strategies to target 
inflammation.  The purpose of this study was to create a more complete description of 






associated molecular patterns (DAMPs), and leukocyte infiltration into the liver, lung, 
kidney, and heart over time.  Furthermore, this study is intended to determine the effects 
of brain death on intestinal permeability, and whether use of DPR would cause decreased 
changes in intestinal permeability, leading to reduced systemic inflammation. 
Materials and Methods 
The methods were performed as explained the Chapter 2: Materials and Methods.  In 
brief, our murine model of brain death was used and rats were sacrificed immediately 
after brain death (time zero) as well as two, four, and six hours after brain death.  Those 
scheduled for DPR received a single intraperitoneal injection of 30 mL of Delflex 
solution.  After brain death rats were resuscitated with enough normal saline to maintain 
a MAP of 80 mmHg and vitals were measured continuously throughout the experiment.  
After sacrifice, tissues were flash frozen in liquid nitrogen and ultimately used for protein 
analysis with ELISA, or digested in collagenase for creation of a single cell suspension 
for flow cytometry.   
Results 
 The heart rate and mean arterial pressure of rats in each groups are displayed in 
Figures 1 and 2.  All rats displayed the characteristic sympathetic surge in heart rate and 
blood pressure, and subsequent decrease associated with brain death.  There were no 




















































































































































































































































































































































































































































The results of a metabolic panel performed immediately after sacrifice is shown in 
Table 1.  Serum levels of sodium were increased at two, four, and six hours compared to 
time zero.  Sodium levels were lower in the two and six hour DPR groups compared to 
the two and six hour targeted IV fluid (TIVF) groups, respectively.  Blood glucose was 
high immediately after brain death and returned to normal by two hours, while glucose 
was increased in the four hour DPR group compared to four hour TIVF.  Alkaline 
phosphatase and total protein were decreased at two, four, and six hours compared to 
time zero.  Amylase was decreased at four and six hours compared to time zero, and 
decreased at six hours compared to two hours.  Albumin was decreased at two, four, and 
six hours compared to time zero and was decreased at six hours compared to all time 
points.  Amylase and total protein were increased in the four hour DPR group over four 
hour TIVF, while albumin was only significantly increased in two hour DPR compared to 
two hour TIVF.  Total IVF was decreased in all DPR groups compared to the TIVF 
groups, but this only reached statistical significance at 2 and 4 hours. 
Flow cytometry results in the blood are shown in figures 3-5.  Granulocytes were 
increased at six hours compared to zero and four hours.  Monocytes trended down but no 
changes reached statistical significance.  Both M1 and M2 activation both trended 




























































































































































Figure 3: Granulocyte count in blood at 0, 2, 4 and 6 hours after brain death as measured 























Figure 4: Monocyte count in blood at 0, 2, 4 and 6 hours after brain death as measured by 

























Figure 5: M1 and M2 activation of monocytes in blood at 0, 2, 4 and 6 hours after brain 






Flow cytometry results in the liver, lung, kidney, and heart tissue are shown in 
figures 6-9.  Tissue neutrophils increased significantly at six hours in the kidney and 
lung.  Tissue macrophages increased at six hours in the kidney and heart.  Classical M1 
activation was increased in all tissues by six hours, while M2 activation only increased 
significantly in the lung at four hours and decreased again at six hours. 
Figure 10 displays results of ELISAs for serum levels of DAMPs high mobility 
group box 1 protein (HMGB-1) and heat shock protein 70 (HSP70).  Levels of HMGB-1 
peaked at two hours but were elevated at two, four, and six hours compared to sham and 
zero hours.  Use of DPR significantly decreased HMGB-1 levels at all time points.  
Levels of HSP70 were increased at six hours compared to all other time points and all 
three DPR groups had significantly reduced HSP70 levels compared to TIVF alone.  
Serum levels of select inflammatory cytokines are shown in Table 2.  Levels of TNF-α, 
IL-4, IL-12, and IL-13 were unchanged over time.  Protein levels of IL-1α was increased 
by DPR at four and six hours, while IL-1β and IL-6 were increased at two, four, and six 
hours compared to sham or time zero and decreased with DPR.  Anti-inflammatory IL-10 














Figure 6:  Neutrophil count in liver, lung, kidney, and heart at 0, 2, 4 and 6 hours after 
brain death as measured by flow cytometry.  *p < 0.05 vs 0 hour. †p < 0.05 vs 2 hour. ‡p 






Figure 7: Macrophage count in liver, lung, kidney, and heart at 0, 2, 4 and 6 hours 
deviation as measured by flow cytometry.  *p < 0.05 vs 0 hour. †p < 0.05 vs 2 hour. ‡p 







Figure 8: Intensity of M1 macrophage activation in liver, lung, kidney, and heart at 0, 2, 4 
and 6 hours as measured by flow cytometry.  *p < 0.05 vs 0 hour. †p < 0.05 vs 2 hour. ‡p 







Figure 9: Intensity of M2 macrophage activation in liver, lung, kidney, and heart at 0, 2, 4 
and 6 hours after brain death as measured by flow cytometry.  *p < 0.05 vs 0 hour. †p < 







Figure 10: Serum protein levels of DAMPs High Mobility Group Box 1 Protein (HMGB-
1) and Heat Shock Protein 70 (HSP70) in sham rats and at 0, 2, 4, and 6 hours after brain 
death.  *p<0.05 v sham. #p<0.05 v 0hr. †p<0.05 v 2h TIVF. ‡p<0.05 v 2h DPR.  ^p<0.05 







































































































































































Levels of intestinal fatty acid binding protein (FABP), a measure of intestinal 
injury, are shown in Figure 11.  Levels of FABP were increased at two, four, and six 
hours compared to sham, and at four and six hours compared to time zero.  Use of DPR 
reduced FABP levels at two, four, and six hours.  Lipopolysaccharide (LPS) levels were 
significantly increased in the TIVF groups at two, four, and six hours, while use of DPR 
kept LPS at sham levels at all time points.  Results of immunohistochemistry staining for 
zona occludins (ZO-1), which is a part of tight junctions, demonstrate a breakdown in 






















Figure 11: Serum protein levels of Fatty Acid Binding Protein (FABP) and 
Lipopolysaccharide (LPS) in sham rats and at 0, 2, 4, and 6 hours after brain death with 
and without DPR.  *p<0.05 v sham. #p<0.05 v 0hr. †p<0.05 v 2h TIVF. ‡p<0.05 v 2h 







Figure 12: Immunohistochemistry staining of tight junctions in ileum after brain death 
with and without DPR.  Brown staining (arrows) indicates higher concentrations of ZO-1 







 While the heart rate and blood pressure did not vary significantly between groups, 
there were significant changes in the final blood chemistry results.  This can be explained 
by the different amount of IV fluid (IVF) the rats received.  As expected, rats that were 
resuscitated for a longer period of time received more IVF.  However, the rats 
resuscitated for two hours received more than half of the fluid given to the four hour rats, 
and almost half of that given to the six hour rats, which is consistent with the observation 
made during the experiments that rats required a large amount of fluid to maintain blood 
pressure immediately after brain death and which was then gradually tapered as the rats 
stabilized.  Dilution from this large volume of IV fluid explains the decreases in alkaline 
phosphatase, amylase, total protein, and albumin seen over time in the TIVF groups.  
Levels of total protein and albumin were higher in all DPR groups, which required less 
IVF compared to their TIVF counterparts, though not all reached statistical significance.  
The increase is blood sodium can be explained by the fact that the rats are receiving 
normal saline, which has a sodium content of 154 mmol/L, and over time their blood 
sodium moves closer to this value.  Again, sodium levels in the DPR groups were 
decreased at two and six hours compared to TIVF alone, likely because of these animals 
received a smaller amount of sodium in their IV fluids.  The increased blood glucose at 
time zero is likely due to the stress response to the sympathetic surge, as this elevated 
blood glucose has returned to normal by two hours.  The DPR group had a higher blood 
glucose at two and four hours, though this only reached statistical significance at four 
hours.  This may be because the dialysis solution contains glucose which gets absorbed 






glucose levels return to normal.  These laboratory results suggest that DPR helps 
maintain more normal, physiologic electrolyte and protein levels during resuscitation 
after brain death. 
Despite the fact that adequate MAP was maintained, brain death did induce a 
significant increase in a number of inflammatory cytokines.  Serum levels of TNF-α did 
not change significantly over time, though this may be due to the relatively short half-life 
of TNF-α in serum.  Levels of powerful pro-inflammatory cytokines IL-1β and IL-6 
increased in only two hours after brain death.  Anti-inflammatory cytokine IL-4 was 
unchanged over time, while IL-10 began increasing at four hours, demonstrating that the 
cytokine response in brain death is not limited to the inflammatory cytokines.  Cytokines 
IL-1β, IL-5, IL-6, and IL-10 were decreased with DPR, demonstrating that it is able to 
prevent the rise of multiple pro- and anti-inflammatory cytokines.  Using DPR actually 
caused an increase in some inflammatory mediators at different time points, such as IL-
1α, IL-2, and IL-17. This could be due to the fact that these cytokines are produced by a 
variety of cells, including leukocytes and endothelial cells, and DPR may affect the 
activity of these different types of cells differently. 
This elevated inflammatory state correlates with our findings in the two DAMPs, 
or alarmins, HMGB-1 and HSP70.  These DAMPs are part of a diverse group of 
molecules which are released in response to tissue injury or infection [34].  HMGB-1 is a 
DNA binding protein which is normally sequestered due to its chemotactic properties, but 
is released into the extracellular medium when tissue cells undergo necrosis.  HSP70 is a 
member of the heat shock protein family which act as chaperones to promote proper 






toll-like receptors to induce inflammation [38].  The results show that both HMGB-1 and 
HSP70 increase after brain death.  Use of DPR decreases serum levels of both these 
DAMPs.  Previous authors have demonstrated that HMGB-1 and HSP70 are increased in 
models of intestinal ischemia [63, 64].  As the primary function of DPR is to improve 
intestinal blood flow, this suggests that either these DAMPs, or their stimuli, are being 
released from necrotic intestinal cells, and that using DPR prevents this from happening.  
However this requires more study to be definitively proven.   
These findings provide more direct evidence that the intestine plays a role in the 
inflammatory process of brain death as well.  Intestinal FABP is usually found only in the 
intestine, and finding it in the serum indicates intestinal damage [65, 66].  Similarly, LPS 
is produced by bacterial within the intestine and it is released into the circulation when 
intestinal permeability increases in times of stress [67].  There were increases in both of 
these proteins in the serum after brain death.  The DPR groups show significant decreases 
in these markers.  In addition, IHC staining shows a breakdown of tight junction integrity 
in the ileum after brain death, further supporting the hypothesis that intestinal 
permeability is increased after brain death, and also demonstrates that using DPR 
prevents this breakdown.  While a few authors have suggested the idea that the intestine 
plays a role in post-brain death inflammation previously [68, 69], it does not yet seem to 
have gained wide-spread acceptance in the literature.  These results not only provide 
further evidence that the intestine is a source of this systemic inflammation, but also that 
DPR is able to prevent these changes in intestinal permeability, which explains how it is 






 These inflammatory signals are associated with increased leukocyte activity.  The 
neutrophils in tissues and blood were all increased at 6 hours, though these levels only 
reached statistical significance in the blood, kidney, and lung.  These results also 
demonstrate the increase is not gradual, but rather that levels remain relatively stable for 
the first four hours, and then increase dramatically at six hours, especially in the kidney.  
The increase at six hours is consistent with multiple previous studies, including Wilhem 
et al. who demonstrated an increase in neutrophils in the heart at six hours after brain 
death [56], as well as an increase in transplanted hearts procured six hours after brain 
death [70], and Danobeitia and associates who showed increased neutrophils in the liver 
after six hours in primates [71].  However, these findings varied from other studies, 
including Wauters and colleagues who found that neutrophils peaked in a bronchial 
lavage sample at three hours in mice [72], and Schuurs and colleagues who found that 
neutrophil infiltration into the rat kidney began almost immediately after brain death and 
increased more gradually [73].  These results demonstrate that procuring organs from rats 
over six hours after brain death results in organs with a higher neutrophil content.  
Neutrophils have been implicated in the process of organ rejection [74-76].  Thus, these 
findings suggest that use of organs procured after this time point could result in higher 
rates of organ rejection, though further study would be needed to definitively prove this.   
Conversely, levels of monocytes in the blood to not change significantly over 
time.   However, within the tissues there is the same pattern of infiltration which was 
observed with the neutrophils, consisting of an increase at six hours that is most dramatic 
in the kidney.  This is similar to the previously mentioned studies in the heart and lung 






death in the rat kidney [15].  Jassem and colleagues demonstrated increased macrophages 
in livers from brain dead donors, though these were from varied time points [77, 78].   
Macrophages in all tissues experienced an increase in M1 activation, which is 
typically pro-inflammatory [48].  This activation appears more gradual compared to the 
sudden increase in infiltration at six hours.  On the other hand, M2 activation, which is 
typically anti-inflammatory [48], did not significant change over time.  This suggests 
that, while the inflammatory process stimulates a more sudden and rapid influx of 
leukocytes at six hours after brain death, macrophage activation is stimulated shortly after 
brain death and gradually increases over time.  In addition, like neutrophils, accumulation 
of macrophages has been associated with delayed graft function and increased graft 
rejection [79-82], and procurement of organs before this time point may result in reduced 
graft rejection or improved graft function, though this has not been proven. 
This time of six hours for leukocyte infiltration contrasts with what has been 
previously been seen after hemorrhage, where this typically occurs earlier.  Like previous 
studies in the brain death, those in hemorrhage are varied.  However, the results generally 
show that neutrophils infiltrate tissues prior to six hours, such as those showing 
neutrophil infiltration in rats in less than an hour in the lung [83], by three hours in 
kidney [84], and the liver at four hours [85].  Similarly, macrophages have been shown to 
infiltrate by four hours in the lung in mice [86], and in the kidney by five hours in rats 
[87].  Neutrophils have been implicated as one of the earliest and primary mediators of 
myocardial damage after ischemia/reperfusion injury in the heart [88] and a pig model of 
hemorrhage has shown increased macrophage and neutrophil infiltration into the heart 






inflammation associated with brain death is not just an ischemia and reperfusion injury 
from labile blood pressure, but must be more complex.  This could be due to hormonal 
changes, the changes or neural stimulation, or other factors that have not yet been 
determined.  While more study is needed to better understand this process, what is clear 
is that the inflammation associated with brain death must be treated as a separate entity 
from that after other types of injury. 
 Multiple previous authors have examined specific aspects of the data presented 
here, including levels of specific inflammatory cytokines after brain death.  However, this 
study looks at changes in these over time.  In addition, most previous studies use mRNA 
to measure cytokine levels, while this one uses the more definitive protein levels.  
Similarly, previous studiesd typically examine only one organ, and frequently only one or 
a few time points.  This study is the first to offer a comprehensive overview of the 
inflammatory processes which occur in the body after brain death in rats allowing for 
comparison among organs and over time.   
Conclusions 
 In conclusion, this study offers an overall picture of the inflammatory effects of 
brain death in rats.  Brain death is associated with an increase in inflammatory cytokines 
and DAMPs, and triggers leukocyte infiltration into the peripheral organs at six hours 
after brain death.  Furthermore, it appears that the intestine becomes increasingly 
permeable after brain death and that this likely contributes to the inflammatory process.  
Using DPR helps preserve intestinal integrity and reduces systemic inflammatory 
mediators and has potential to improve organ inflammation.  While further study is 






step in understanding the complex changes that occur in brain dead donors that go on to 





























THE EFFECT OF DIRECT PERITONEAL RESUSCITATION ON LEUKOCYTE 
ACTIVITY IN THE LUNG 
Overview 
Background: Brain death is associated with significant lung injury and inflammation.  
This has been associated with worse long-term outcomes for transplanted organs 
procured from brain death donors.  Direct peritoneal resuscitation improves blood flow to 
the visceral organs, reduces systemic inflammation in brain death, and improves lung 
procurement rate.  The effects of DPR on macrophage and neutrophil infiltration in the 
lungs is not known. 
Methods:  Male Sprague-Dawley rats were anesthetized and had a tracheostomy and 
arterial and venous cannulas placed.  Brain death was achieved by inserting a 4F Fogarty 
catheter into the skull and slowly inflating the balloon.  Rats were resuscitated with 
normal saline to maintain a mean arterial pressure of 80 mmHg (targeted intravenous 
fluid, TIVF) and DPR animals also received an intraperitoneal injection of commercial 
peritoneal dialysis solution.  Rats were sacrificed at zero, two, four, and six hours after 
brain death and tissue samples taken.  Protein levels were assessed using quantitative 
ELISA.  Flow cytometry and immunohistochemistry were used to quantify neutrophil 
and macrophage infiltration.   
Results:  At all time points, use of DPR downregulated multiple inflammatory cytokines 






death, adhesion molecules intracellular adhesion molecule, E-selectin, and P-selectin 
were increased above sham.  At each of these time points use of DPR caused a significant 
decrease in protein expression.  A similar pattern was seen in vascular adhesion molecule 
at two and six hours.  Infiltration of macrophages and neutrophils was substantially 
decreased with DPR on immunohistochemistry straining and trended down at six hours 
with DPR, though this difference was not statistically significant on flow cytometry.  
Macrophage activation was unchanged by DPR.   
Conclusions:  Animals which received TIVF alone had significant increases in 
inflammatory cytokines within the lung tissue, leading to adhesion molecule expression 
and ultimately in leukocyte infiltration.  All of these stages of inflammation were 
downregulated by use of DPR.  Using DPR in brain dead organ donors shows promise as 


















 Brain death is associated with significant lung injury.  In addition to the contusion 
and aspiration that frequently accompany the initial injury, brain dead patients frequently 
develop neurogenic pulmonary edema [6].  This edema is theorized to originate from two 
possible sources: hypertension causing increased capillary pressure and direct pulmonary 
capillary damage [90], or increased capillary permeability due to α-adrenergic stimulation 
[91].  Brain death also causes significant systemic inflammation [16] as well as 
inflammation and apoptosis within the lung tissue itself [92-94].  When these lungs are 
procured for transplantation, this inflammation leads to worse ischemia-reperfusion 
injury [95] and higher rates of rejection [96].  This lung damage can be worsened by 
resuscitation after brain death.  Large amounts of intravenous (IV) crystalloid fluid is 
often given to support blood pressure, but this can worsen lung edema [7].  In part 
because of this inflammation and edema, only 20% of lungs from brain dead donors are 
considered suitable for transplantation [57]. 
 Because of these problems with conventional IVF resuscitation, DPR has 
potential to improve organ donor resuscitation.  Previous studies have demonstrated that 
use of DPR in a rat model of brain death leads to improved visceral organ blood flow, 
reduced organ edema, and reduced serum levels of multiple inflammatory cytokines [41].  
Using of DPR in brain dead human organ donors improved the rate of organ procured per 
donor, specifically by increasing rates of lung procurement [27].  The purpose of this 
study is to determine whether the anti-inflammatory effects of DPR would lead to a 








The methods were performed as outlined in Chapter 2: Materials and Methods.  In brief, 
our murine model of brain death was used and rats were sacrificed immediately after 
brain death (time zero) as well as two, four, and six hours after brain death.  Those 
scheduled for DPR received a single intraperitoneal injection of 30 mL of Delflex 
solution.  After brain death rats were resuscitated with enough normal saline to maintain 
a MAP of 80 mmHg and vitals were measured continuously.  After sacrifice, lung tissue 
was collected and flash frozen in liquid nitrogen and ultimately used for protein analysis 
with ELISA, digested in collagenase for creation of a single cell suspension for flow 
cytometry, or preserved in neutral buffered formalin for immunohistochemistry staining.   
Results: 
 Levels of cytokines and chemokines in the lung tissue are displayed in Table 3.  
Multiple pro-inflammatory cytokines, including IFN-γ, TNF-α, IL-1α, IL-1β, and IL-6 
were increased after brain death and decreased with the addition of DPR.  Anti-
inflammatory mediators IL-4 and IL-10 were also increased at two, four, and six hours 
compared to sham and decreased with DPR.  Levels of IL-12 peaked at four hours and 
were decreased by DPR at that time, while levels of IL-2 did not increase until six hours 




































































































































































































Adhesion molecules intracellular adhesion molecule (ICAM), vascular adhesion 
molecule (VCAM), E-selectin, and P-selectin are shown in figures 13-16.  Levels of 
ICAM, E-selectin, and P-selectin remained equivalent to sham levels at two hours, then 
increased at four hours and six hours in the TIVF groups, and were decreased with DPR 
compared to TIVF at the same time point.  Protein levels of VCAM were increased at 
two and six hours compared to sham and decreased at both time points with DPR.  Levels 
of VCAM were equivalent to sham at four hours with and without DPR. 
Results of the flow cytometry analysis for neutrophils are shown in figure 17.  In 
the TIVF group there is a large increase in the number of neutrophils that infiltrate the 
tissue at six hours.  Use of DPR reduced the size of this increase, though the difference 
between these two points failed to reach statistical significance.  Neutrophil activation 
measured by myeloperoxidase (MPO) activity is shown in figure 18.  The MPO activity 
increased immediately after brain death (time zero) compared to sham.  The MPO 
activity further increased at six hours.  Use of DPR reduced MPO activity at two, four, 
and six hours compared to the TIVF group at each respective time point. 
Macrophage infiltration, measured by flow cytometry, increased at six hours, and 
this increase was dampened by DPR, though this was not a statistically-significant 
change (Figure 19). Use of DPR did not change M1 activation , and decreased M2 
activation at four hours compared to the four hour TIVF group, but the TIVF and DPR 









Figure 13: Levels of ICAM protein in lung tissue in sham rats and at 0, 2, 4, and 6 hours 







Figure 14: Levels of VCAM protein in lung tissue in sham rats and at 0, 2, 4, and 6 hours 







Figure 15: Levels of E-selectin protein in lung tissue in sham rats and at 0, 2, 4, and 6 







Figure 16: Levels of P-selectin protein in lung tissue in sham rats and at 0, 2, 4, and 6 







Figure 17: Flow cytometry results of neutrophils within the lung in sham rats and at 0, 2, 



























Figure 18: Myeloperixodase activity assay within the lung in sham rats and at 0, 2, 4, and 







Figure 19: Flow cytometry results showing macrophage infiltration in the lung in sham 

























Figure 20: Flow cytometry results showing M1 and M2 macrophage activation in the 
lung in sham rats and at 0, 2, 4, and 6 hours after brain death with and without DPR. *p < 






Immunohistochemistry staining reflected the increase in macrophages and 
neutrophils in the tissue at six hours compared to time zero and the slight decrease with 
DPR (Figures 21 and 22).  Pathologist descriptions (Table 4) show that use of DPR at six 
hours significantly improved lung edema and hemorrhage and mildly reduced leukocyte 
infiltration.  Compared to sham, the process of brain death itself caused some edema, 












































































































































































































































































Table 4  
Pathology descriptions of lung tissue in sham rats and at time zero, six hours, and six 
hours with DPR 
 Sham 0 hour 6 hour 6 hour DPR 
Edema Absent Mild-moderate Moderate-Severe Mild-moderate 
Hemorrhage Absent Absent Moderate-Severe Focal 
Quantity of 
Neutrophils 
None Few  Numerous Numerous 
 Location of 
Neutrophils 







































 The inflammation following brain death, or any inflammatory stimulus, requires 
leukocytes to move out of the blood stream and into the tissues.  This requires a complex 
series of steps including adhering to the blood vessel wall, rolling along the wall, and 
traversing the vessel wall into the tissue.  This process depends on the interaction of 
numerous proteins on the cells and on the vessel wall.  P-selectin is expressed by the 
endothelium to initially attract and adhere leukocytes, while E-selectin is expressed by 
activated endothelium to slow the adherent leukocytes and help them roll [97].  Similarly, 
ICAM and VCAM are expressed by the endothelium to bind ligands on the leukocytes to 
cause them to adhere to the vessel wall in preparation for transmigration [97, 98].  Thus, 
targeting these molecules is a method of reducing leukocyte infiltration into tissues in 
inflammation [99]. 
These data help delineate the timing of events that lead to this leukocyte 
infiltration and lung injury after brain death.  The process of brain death and resuscitation 
appears to cause at least a temporary increase in all cytokines, both pro- and anti-
inflammatory, as there were increases in IL-4 and IL-10, as well as pro-inflammatory 
cytokines IL-1α, IL-1β, IL-6, IL-18, IFN-γ and TNF-α.  However, the pathology staining 
makes it clear that the overall effect is pro-inflammatory, associated with edema, 
hemorrhage, and lung injury.  While the timing of individual cytokines may vary, a 
number of vital pro-inflammatory cytokines, such as IFN-γ, IL-1α, and IL-1β were 
increased at two hours, and TNF-α was increased immediately after brain death, 






events which follow brain death.  While inflammation may begin as a systemic process, it 
induces increased inflammatory mediators within the lung tissue itself.  
Several of the elevated inflammatory cytokines, including IL-1 and TNF-α, also 
cause the expression of leukocyte adhesion molecules [100].  In addition, these results 
show that tissue levels of CCL-2, an attractant for macrophages, increased significantly 
after two hours though most dramatically at six hours, while CCL-5, a chemokine 
primarily for T-cells, peaks at two hours and then gradually decreases.  These findings 
demonstrate that at two hours after brain death, the lung tissue is preparing for an influx 
of leukocytes.  Protein levels of leukocyte adhesion molecules then become increased in 
the lung at four hours after brain death.  This then leads to infiltration of neutrophils and 
macrophages into the lung tissue between four and six hours after brain death.  This is 
consistent with previous studies that have found significant leukocyte infiltration in the 
lungs at six hours [72].  However, these data demonstrate that instead of a gradual 
increase, this is a rapid increase that occurs between four and six hours after brain death 
in the rat. 
These findings vary from those found in other types of shock.  After hemorrhagic 
shock several authors have found increased neutrophil infiltration and ICAM expression 
increased three hours after hemorrhage in rats and mice [83, 101].  Other authors have 
examined lungs after ischemia and reperfusion and injury and found increased 
macrophages, neutrophils, and ICAM after two to four hours in rats [102, 103].  Sheridan 
et al. found increased lung neutrophil accumulation after four hours in a rat model of 
sepsis [104].  While these studies are variable, they all suggest that, compared to the data 






of injury when compared with brain death.  This could be due to a number of factors that 
make brain death different from other types of injury, such as the neural and hormonal 
changes.  In addition, previous studies have shown that inflammation increased both with 
hemorrhage and resuscitation [83, 105], so it is also possible that the resuscitation after 
brain death, which relies more heavily on large volumes of crystalloid solution, may be 
an additional source of these differences. 
Use of DPR affects each stage in the process of leukocyte infiltration.  While the 
results were not statistically significant, the flow cytometry suggests that use of DPR 
blunts the increase in macrophage and neutrophils seen in animals which received TIVF 
alone.  This is likely due to the fact that DPR causes a downregulation of adhesion 
molecules.  Even though macrophages are activated just as strongly when DPR is given, 
this reduced expression of adhesion molecules prevents their moving into the lung tissue 
as easily.  The adhesion molecule expression is, in turn, determined by the inflammatory 
cytokines, especially IL-1 and TNF-α.  These are the primary stimuli for adhesion 
molecule upregulation, and were also downregulated with DPR.  Other cytokines that are 
markers of inflammation, such as IL-6, IL-12, and IFN-γ were also downregulated with 
DPR, suggesting that the lungs are in an overall less inflammatory state.  However, the 
change in cytokines presents a dilemma regarding cause and effect, as these cytokines 
stimulate the adhesion molecules which promote leukocyte infiltration, and also promote 
macrophage and neutrophil activation, but traditionally macrophages and neutrophils are 
one of the primary sources of inflammatory cytokines.  This suggests that inflammatory 






The cause of the systemic inflammation associated with brain death is a source of 
debate.  It has been suggested that the process of brain death is associated with damage to 
the blood-brain barrier, and that inflammatory mediators are released from the brain itself 
[16, 17] or from endothelial damage [91].  Other authors have suggested that some of this 
inflammation arises from the intestine [69, 106], and the data presented in chapter four 
supports this.  This is consistent with the demonstrated increases in intestinal 
permeability in other types of shock [12, 14, 107].  Furthermore, it has been shown that 
renal ischemia and reperfusion can lead to changes in neutrophil margination within the 
lung, demonstrating that the lungs can suffer injury from an insult to an entirely different 
organ [108].  The fact that changes within the intestine can affect the lungs explains how 
DPR, a therapy applied in the abdomen and that targets intestinal blood flow, is able to 
reduce systemic inflammation and produce changes within the lungs. 
While DPR appears to affect the mechanism for leukocyte infiltration, it does not 
reduce leukocyte activation.  While there are some small differences in M2 macrophage 
activation at four hours after brain death, the TIVF and DPR groups are equivalent by six 
hours.  The MPO activity of neutrophils was reduced by DPR at each time point, though 
since this measures the overall activity within the tissues it cannot be determined from 
this data whether this is due to changes in the activity of the individual neutrophils, or 
due to a reduction in the number of them present in the tissue, or both.  This suggests 
that, while the upregulation of leukocyte adhesion molecules can be altered by the 
resuscitation process, the leukocyte activation is triggered by the process of brain death 
itself and cannot be altered this way.  This is consistent with our results that compare 






occurs in this time frame, there is an increase in MPO activity.  In addition, there were 
small but notable increases in leukocytes, inflammation, and edema in the lung tissue at 
time zero compared to sham animals, even though they received less total IV fluid.  
Clearly the process of brain death itself, and not just its subsequent labile blood pressures 
and resuscitation, leads to inflammation and edema within the lungs.  While using DPR is 
not sufficient to prevent all of these changes, it does help reduce edema, inflammation, 
and leukocyte infiltration, explaining how using DPR helps increase the number of lungs 
suitable for transplantation. 
Conclusions 
In conclusion, our data suggest that by maintaining the blood flow to the intestine 
during brain death, this decreases the permeability of the intestine, thus preventing the 
release of inflammatory mediators.  This, in turn, leads to improvements in inflammatory 
signals within the lung tissue, which decreases the upregulation of leukocyte adhesion 
molecules and ultimately reduces the infiltration of macrophages and neutrophils.  While 
further study is needed to confirm the causative nature of these findings, use of DPR 














THE EFFECT OF DIRECT PERITONEAL RESUSCITATION ON LEUKOCYTE 
ACTIVITY IN THE KIDNEY 
Overview 
Background:  Brain death is associated with significant inflammation and leukocyte 
activity within the peripheral organs including the kidneys.  This inflammation is 
theorized to be the primary reason that multiple studies show reduced graft survival when 
transplanted organs are procured from brain dead donors.  Therefore, reducing 
inflammatory mediators in brain dead donors and leukocyte infiltration into organs may 
improve transplant outcomes.  Direct peritoneal resuscitation (DPR) has been shown to 
reduce systemic inflammation after brain death, but its effects on leukocytes within the 
kidney are not know. 
Methods:  Brain death was achieved in male Sprague-Dawley rats by inserting a 4F 
Fogarty catheter into the skull and inflating the balloon at 1cc/hr.  Rats were resuscitated 
with normal saline to maintain a mean arterial pressure of 80 mmHg (targeted 
intravenous fluid, TIVF) and DPR animals also received 30cc of intraperitoneal 
peritoneal dialysis solution.  Rats were sacrificed at zero, two, four, and six hours after 
brain death and tissue samples taken.  Protein levels were assessed using quantitative 
ELISA.  Neutrophil and macrophage infiltration was assessed using flow cytometry. 
Results:  Protein levels of adhesion molecules ICAM, VCAM, E-selectin, and P-selectin 






reduction in levels at each time point when compared to their respective TIVF groups.  
Flow cytometry revealed that the quantity of macrophages and neutrophils was 
equivalent in the TIVF and DPR groups at two and four hours after brain death, but at six 
hours after brain death the TIVF group had a large increase which was significantly 
decreased with DPR.  Neutrophil myeloperoxidase activity was decreased with DPR, but 
macrophage activation was increased and two and four hours and equivalent at six hours. 
Conclusions:  Use of DPR reduces systemic inflammation, leading to reduced adhesion 
molecule expression and decreasing leukocyte infiltration into the kidneys.  Application 
of DPR to the resuscitation of brain dead donors has the potential to reduce the 




















 The process of brain death is associated with significant inflammation [15, 16].  
This inflammation is frequently cited as the reason that transplanted organs from brain 
dead donors are associated with higher rates of graft failure [16, 60, 109].  The kidneys 
are not immune to this inflammation.  Studies have shown increased cytokines and 
chemokines in human and rat kidneys after brain death at the time of procurement [59, 
110].  This has lead a number of authors to suggest methods for targeting inflammatory 
mediators in an attempt to improve transplant outcomes [111].  Therapies such as 
dopamine [112], complement inhibitors [113], or vagal stimulation [114] have shown 
promise in animal models but have not gained widespread acceptance in the treatment of 
human organ donors. 
Direct peritoneal resuscitation is an innovative method of resuscitation that 
improves blood flow to the visceral organs, but does not directly increase renal blood 
flow [21].  However, DPR has been shown to reduce systemic inflammatory cytokines 
after multiple types of shock [22, 26, 41, 115].  Using DPR in brain dead human donors 
has also been shown to increase the rate of organ procurement [27], suggesting that using 
DPR during resuscitation of brain dead donors exerts anti-inflammatory effects within the 
organs.  However, no study has examined the effects of DPR specifically within the 
kidney.  Kidneys are the most frequently transplanted organ [9], and leukocytes within 
transplanted organs have been associated with increased rates of rejection [79].  
Therefore, the purpose of this study was to determine whether use of DPR would lead to 
a reduction in leukocyte infiltration into the kidney, as well as the mechanism through 







The methods were performed as explained in Chapter 2: Materials and Methods.  In brief, 
our murine model of brain death was used and rats were sacrificed immediately after 
brain death (time zero) as well as two, four, and six hours after brain death.  Those 
scheduled for DPR received a single intraperitoneal injection of 30 mL of Delflex 
solution.  Prior to brain death rats were resuscitated with enough normal saline to 
maintain a MAP of 80 mmHg and vitals were measured continuously.  After sacrifice, 
kidney tissue was flash frozen in liquid nitrogen and ultimately used for protein analysis 
with ELISA, or digested in collagenase for creation of a single cell suspension for flow 
cytometry.   
Results: 
 Results of protein levels of ICAM and VCAM are shown in figures 23 and 24 
while protein levels of E-selectin and P-selectin are shown in figures 25 and 26.  Both 
ICAM and VCAM peak at two hours but are increased above sham at two, four, and six 
hours.  Use of DPR reduced ICAM and VCAM to sham levels at all time points when 
compared to the respective TIVF groups.  E-selectin was increased at four and six hours 
after brain death and reduced at both time points with DPR.  P-selectin was increased at 












Figure 23: Levels of ICAM protein in kidney tissue in sham rats and at 0, 2, 4, and 6 







Figure 24: Levels of VCAM protein in kidney tissue in sham rats and at 0, 2, 4, and 6 







Figure 25: Levels of E-selectin protein in kidney tissue in sham rats and at 0, 2, 4, and 6 







Figure 26: Levels of P-selectin protein in kidney tissue in sham rats and at 0, 2, 4, and 6 






The quantification of neutrophils by flow cytometry is shown in Figure 27.  The 
DPR and TIVF groups were equivalent to each other at two and four hours, but at six 
hours the use of DPR significantly reduced the increase in neutrophils seen in the TIVF 
group.  The MPO assay shows that neutrophil activation was increased by the process of 
brain death itself, increasing above sham levels in the time zero animals (Figure 28).  
Neutrophil activity was further increased at four and six hours above the time zero levels, 
and decreased at both those time points with the addition of DPR. 
Macrophage infiltration is shown in Figure 29.  Like the neutrophils, the two 
experimental groups were equivalent at two and four hours.  However, the increase in 
macrophages in the TIVF group is significantly reduced in the DPR group.  Macrophage 
M1 activation was unchanged by DPR (Figure 30).  Conversely, M2 activation was 
equivalent between the TIVF and DPR groups at two and four hours, but significantly 
















Figure 27: Flow cytometry results of neutrophil infiltration into the kidney at 0, 2, 4, and 
























Figure 28: Myeloperoxidase activity assay in the kidney in sham rats and at 0, 2, 4, and 6 







Figure 29: Flow cytometry results of macrophage infiltration into the kidney at 0, 2, 4, 

























Figure 30: Flow cytometry results showing macrophage activity in the kidney at 0, 2, 4, 







Protein levels of cytokine within the kidney tissue are displayed in Table 5.  
Levels of pro-inflammatory TNF-α and IL-6 were increased at four and six hours, but 
TNF-α was only significantly decreased by DPR at four hours while IL-6 was decreased 
at both time points.  Levels of IL-1α, IL-12, and IL-13 were not significantly changed at 
any time point, while IL-1β increased at two hours and then dramatically at six hours, and 
was decreased at both these time points with DPR.  Interleukin 2 was increased starting at 
two hours and unchanged by DPR, while IL-18 and IFN-γ were increased above sham at 
two, four, and six hours but only reduced by DPR at some of these times.  Chemokine 
CCL-2 was statistically increased at two hours, and then again more significantly at six 















































































































































































































 Kidneys are the most frequently transplanted organ in the United States [9].  
However, in 2009 there were over 871,000 people in the US requiring dialysis due to 
renal failure, many of whom would benefit from transplantation [116].  Unfortunately, 
those who receive a transplant do not always remain off dialysis, as the number of grafts 
still functioning 10 years after transplant is on average only 34-48% [117].  The most 
common reason for graft failure is chronic graft rejection, followed by glomerulonephritis 
and infection [118].  Kidneys procured from brain dead donors are associated with worse 
long-term outcomes than those from other donors, worsening this problem [60].  
This study helps delineate the inflammatory process within the kidney during 
brain death.  Much like within the lung, a number of inflammatory cytokines increase 
within the kidney tissue within two hours of brain death, including IL-1β, IL-2, IL-17, 
IL-18, and IFN-γ.  However, IL-6 and TNF-α take four hours and IL-1α does not change 
at all.  It appears that overall, the kidney is less responsive to the process of brain death 
than the lungs, at least over the period studied.  This could be in part because of the 
significant blood flow to the kidneys, especially in brain death as there is a loss of the 
neural and hormonal signals that typically cause renal vasoconstriction.   
These inflammatory cytokines are one of the triggers for leukocyte adhesion 
molecules.  Previous authors have measured levels of adhesion molecules within the 
kidney after brain death and found varied results.  Skrabal et al. found no difference in 
ICAM levels at six hours in a pig model of brain death [119], while van der Hoeven and 
colleagues found that ICAM and VCAM were increased in rats at six hours but not at one 






death leads to an increase in E-selectin expression at the time of organ procurement [59], 
while Schuurs and associates saw increased E-selectin as early as 30 minutes after brain 
death in rats [73].  In contrast, this study not only looks as multiple time points, unlike 
most of these studies, but also measures actual protein levels instead of mRNA to 
quantify these adhesion molecules.  These findings demonstrate that ICAM and VCAM 
are increased as soon as two hours after brain death, and P-selectin is increased 
immediately after brain death, while E-selectin takes four hours to increase.   
Use of DPR downregulates the expression of all of these molecules, likely by 
downregulating their primary stimuli.  There are many triggers for increased expression 
of these adhesion molecules, including most commonly endothelial injury and release of 
inflammatory cytokines such as IL-1 and TNF-α [99, 121, 122].  We have previously 
demonstrated that use of DPR downregulates these mediators in rat serum [41], by 
improving intestinal blood flow [21] and preventing increased intestinal permeability as 
shown in chapter 4.  These data also demonstrate reductions in TNF-α and IL-1β within 
the kidney tissue.  Thus, by preventing this stimulation, DPR prevents the upregulation of 
leukocyte adherence proteins. 
The level of adherence proteins correlates directly with leukocyte infiltration.  
The timing for this infiltration has been varied in different experiments looking at brain 
death.  For example, infiltration of macrophages and neutrophils into the kidney was 
observed at six hours by Takada et al. [15] while Schuurs and colleagues found an 
increase in cortical neutrophils that began at 30 minutes and peaked at two hours after 
brain death, as assessed by immunohistochemistry [73].  These data show a definitive 






hours, the TIVF group is equivalent to sham, and DPR causes no change.  However, 
while the significant infiltration occurs at six hours in the TIVF rats, use of DPR is able 
to significantly reduce this increase.  This suggests that the use of DPR leads to a 
significant reduction, or at least a delay, in the infiltration of leukocytes into the kidney.  
While causation has not been definitively proven, it is likely that this is due to the 
reduction in adhesion molecules which are necessary for sequestration.  Procurement of 
organs prior to this time in rats, or in the equivalent time of approximately 18-24 hours in 
humans, may lead to transplantation of leukocyte-reduced organs and the potential for 
reduced immunogenicity.  However, more study is needed to verify these hypotheses.   
The flow cytometry demonstrates a dramatic increase in macrophage and 
neutrophil infiltration into the rat kidney between four and six hours after brain death.  
This is different than most findings that have examined leukocyte infiltration after other 
types of shock.  Awad et al. found that neutrophils had increased in the mouse kidney 
210% above baseline only two hours after ischemia and reperfusion [108].  Ysebaert and 
colleagues found increased MPO activity in rats within one hour of reperfusion, but noted 
only rare neutrophils on H&E staining [123].  They also found a gradual increase in 
macrophages over the first 12 hours.  Other authors found infiltration to occur prior to 
three and five hours after hemorrhage [84, 87].  Conversely, Langenberg et al. found no 
histologic changes in the kidneys of sheep 48 hours after infusion of IV Escherichia coli 
simulating septic shock [124].  The variability of these different experiments, including 
use of different species, different models, and the intrinsic variability with any in vivo 
model, makes the determination of a specific time for leukocyte infiltration difficult.  






ischemia/reperfusion than the current findings show brain death.  This implies that the 
inflammatory process associated with brain death is not merely due to ischemia and 
reperfusion during the process of herniation or resuscitation, but is fundamentally 
different.  This difference could be due to the other changes that occur with brain death, 
such as endocrine changes, hormone levels, changes in catecholamine release, or some 
unknown factor released during the process.  Further studies are needed to determine 
which, if any, of these is a factor in brain death. 
While DPR causes a reduction in the quantity of macrophages moving into the 
tissues, it does not reduce the degree of macrophage activation.  Macrophage activation is 
a complex process that is divided into M1, or classical activation, and M2 activation, 
which is typically more anti-inflammatory.  Classical activation is triggered by INF-γ 
followed by interaction with specific molecules such as toll-like receptors [48].  In this 
study we found that DPR caused a temporary increase in M1 activation at two and four 
hours, and the groups became equivalent at six hours.  In a previous study we found that 
use of DPR causes an increase in IFN-γ at two hours [41], which may explain this 
finding.  On the other hand, use of DPR did reduce myeloperoxidase activity, which 
reflects neutrophil activity.  This may represent the reduction in neutrophil quantity, or 
may reflect a reduction in neutrophil activity, or both.  Neutrophils are stimulated by a 
number of factors, including IL-8, platelet activating factor, leukotrienes, and 
complement proteins [125], and the majority of these have not yet been tested but may be 
affected by DPR.  Further study will be needed to determine the mechanism that alters 






A direct comparison between the kidney and lung results is difficult, as different 
amounts of tissue were used for the different experiments.  However, some interesting 
trends are suggested.  As mentioned earlier, it appears based on the behavior of individual 
cytokines that the kidney has a more blunted initial inflammatory response compared to 
the lungs.  However, despite the lower and slower initial stimulus, the kidney appears to 
have an even more dramatic response in terms of leukocyte infiltration.  For example, 
macrophages within the lung increase 2.2 times in six hours but in the kidney they 
increase over seven-fold.  Compared to the lung, the adhesion molecules within the 
kidney generally increased earlier, so it is possible that the inflammatory process within 
the kidney occurs faster and thus is more advanced by six hours, and that the time points 
chosen did not adequately capture this initial inflammatory response.  Another possibility 
is that this may also be a consequence of differences between the two organs themselves: 
the lung tissue is typically full of resident macrophages, and the lungs are constantly 
assaulted by stimuli through their connection to the outside world, which may make them 
more accustomed to a constant low level of inflammation and require a larger stimulus.  
Alternatively, the presence of macrophages within the kidney is generally associated with 
pathology, and thus the kidney tissue may only require a smaller stimulus to produce a 
big leukocyte response. 
Multiple investigators have attempted to reduce the inflammatory activity in the 
kidneys associated with brain death by targeting cytokines, leukocytes, or other stimuli.  
However, no method has gained widespread use in the medical community.  This study 
both delineates the timeline of leukocyte infiltration into the kidney after brain death and 






death inflammation by preventing the intestinal ischemia that triggers the release of some 
of these inflammatory mediators and prevents the stimulation of adhesion molecules and 
subsequent leukocyte infiltration. 
Conclusions 
Use of DPR causes a significant reduction in expression of ICAM, VCAM, E-selectin, 
and P-selectin, likely by reducing their primary stimuli.  This in turn likely causes the 
significant reduction in macrophage and neutrophil infiltration into the kidney.  However, 
DPR does not appear to alter the course of macrophage activation.  While these findings 
represent only preliminary data, this suggests that use of DPR could lead to the ability to 





















 The complex physiologic processes associated with the progression to brain death 
lead to significant systemic inflammation.  We have provided a clear timeline and 
suggested a mechanism for how this occurs (Figure 31).  Brain death is associated with 
profound hypotension that leads to intestinal ischemia.  This in turn leads to increased 
intestinal permeability, allowing for the release of more inflammatory cytokines and 
DAMPs such as HMGB-1, and HSP70.  This systemic increase begins within two hours 
of brain death.  These act as signals to stimulate the expression of leukocyte adhesion 
molecules within the lungs and kidneys between two and four hours after brain death.  
Finally, these changes in leukocyte adhesion molecules leads to an increase in leukocyte 
infiltration into the tissues by six hours.   Direct peritoneal resuscitation prevents the 
intestinal ischemia that initiates this progression, thus reducing the macrophages and 







Figure 31.  Schematic diagram showing the proposed sequence of events and relevant 
time points of inflammation and leukocyte infiltration after brain death.  DPR alters this 






In addition, we showed that DPR does not have a prolonged effect on the 
activation of macrophages.  Since DPR is applied after brain death has occurred, it 
appears that this is too late to prevent this activation.  Other factors we examined, such as 
some of the leukocyte adhesion molecules, showed a significant difference between those 
measured in sham animals when compared to those measured immediately after brain 
death, suggesting that the process of brain death itself induces some significant and 
immediate changes within the organs.  This suggests that it may not be possible to fully 
prevent the rise in systemic inflammation that occurs after brain death, or that to do so 
may require intervention before brain death occurs.  While DPR has clear limitations to  
its application and effects, it shows considerable potential for its use in reducing 
inflammation in brain death. 
Limitations 
 These studies have multiple limitations.  First, the groups are relatively small for 
an in vivo model which is intrinsically variable.  This may be why some of the observed 
differences failed to reach statistical significance.  Next, these observations are limited to 
the first six hours after brain death, largely because with time the rats used become 
increasingly unstable, making longer observation periods difficult.  It is possible that after 
this time point subsequent measurements would show that the groups become equivalent, 
or that DPR would have a different effect.  In addition, the lack of further time points 
means that we can only state that using DPR reduces leukocyte at the times measured, 
and it is possible that using DPR only delays this infiltration, which cannot be seen 
without a longer observation period.  While our data find a strong association between 






proven.  The effects of DPR on both are certainly suggestive of a relationship, but further 
study would be needed to clearly demonstrate a cause and effect.  Also, while we have 
demonstrated that use of DPR in brain dead donors offers an opportunity to procure 
leukocyte-reduced organs, it has not been proven that this offers any long-term benefit to 
the transplant recipient.  Finally, as this is an animal study, similar studies in humans 
would be necessary demonstrate whether these findings are also valid in human subjects. 
Future Directions 
 There are several next steps for this work.  One is to definitely demonstrate the 
connection between brain death and intestinal permeability which can be done in an in 
vivo model using a marker such as Evan’s blue dye or labeled albumin infused prior to 
brain death, and then measuring it in the intestine before and after brain death.  In order 
to definitively show the connection between inflammatory cytokines, adhesion 
molecules, and leukocyte infiltration, antibodies to inflammatory cytokines or the 
leukocyte adhesion molecules could be used to block and individual step to determine 
whether a subsequent step is affected as expected.  Finally, an animal model of lung and 
kidney transplantation could be used to determine whether the leukocyte reduction prior 
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LIST OF ABBREVIATIONS 




ATP adenosine triphosphate 
BMP, beats per minute 
cc, cubic centimeter 
CD, cluster of differentiation 
CMP, complete metabolic panel 
CR, conventional resuscitation 
CXCR2, C-X-C motif chemokine receptor 2 
dL, deciliter  
DAMPs, damage associated molecular proteins 
DNA, deoxyribonucleic acid 
DPBS, dulbecco’s phosphate buffered saline 
DPR, direct peritoneal resuscitation 
ELISA, enzyme-linked immunosorbent assay 
F, french 
FABP, fatty acid binding protein 







HA, hyaluronic acid 
HMGB-1, high mobility group box 1 protein 
HR, heart rate 
HSP70, heat shock protein 70 
ICAM, intracellular adhesion molecule 
ICP, intracranial pressure 
ICU, intensive care unit 
IFN-γ, interferon γ 




IVF, intravenous fluid 
kg, kilogram 
L, liters 
LPS, lipopolysaccharide  












mRNA, messenger ribonucleic acid 
NBF, neutral buffered formalin 
NS, normal saline 
PE, phycoerythrin 
PFA, paraformaldehyde  
pH, acidity 
RP-1, antibody to rat neutrophils 
TBI, traumatic brain injury 
TGF-β, transforming growth factor β 
TIVF, targeted intravenous fluid 
TNF-α, tumor necrosis factor α 
U, units 
VCAM, vascular adhesion molecule 
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